Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions
(NOT-OD-20-106)
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Nursing Research
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
(PAR-20-216)
National Center for Complementary and Integrative Health
Application Receipt Date(s):
New Applications: July 20,2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023
Resubmission and Revision: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
(PAR-20-217)
National Center for Complementary and Integrative Health
Office of Dietary Supplements
Application Receipt Date(s):
New Applications: July 20,2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023
Resubmission Applications: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
(PAR-20-218)
National Center for Complementary and Integrative Health
Office of Dietary Supplements
Application Receipt Date(s):
New Applications: July 20,2020; February 01, 2021; October 01, 2021; June 01, 2022; February 01, 2023
Resubmission Applications: July 20, 2020; February 17, 2021; October 15, 2021; June 15, 2022; February 15, 2023
NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
(RFA-DK-20-002)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s):
October 20, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
(RFA-RM-20-012)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s):
August 21, 2020
No late applications will be accepted for this Funding Opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.